Biomedical Engineering Reference
In-Depth Information
136. Manach C, Morand C, Gil-Izquierdo A, Bouteloup-Demange C, Remesy C. 2003.
Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion
of two doses of orange juice. Eur J Clin Nutr 57(2):235-242.
137. Kuhnau J 1976. The flavonoids. A class of semi-essential food components: their role in
human nutrition. World Rev Nutr Diet 24:117-191.
138. Harborne JB, Williams CA. 2000. Advances in flavonoid research since 1992. Phyto-
chemistry 55(6):481-504.
139. Scalbert A, Williamson G. 2000. Dietary intake and bioavailability of polyphenols. J Nutr
130(8S Suppl):2073S-2085S.
140. Vinson JA, Hao Y, Su X, Bose P. 1998. Phenol antioxidant quantity and quality in foods:
vegetables. J Agric Food Chem 46(9):3630-3634.
141. Vinson JA, Su X, Zubik L, Bose P. 2001. Phenol antioxidant quantity and quality in foods:
fruits. J Agric Food Chem 49(11):5315-5321.
142. Middleton E, Jr., Kandaswami C, Theoharides TC. 2000. The effects of plant flavonoids
on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol
Rev 52(4):673-751.
143. Havsteen BH. 2002. The biochemistry and medical significance of the flavonoids. Phar-
macol Ther 96(2-3):67-202.
144. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. 1993. Dietary antiox-
idant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet
342(8878):1007-1011.
145. Kohno H, Tanaka T, Kawabata K, Hirose Y, Sugie S, Tsuda H, Mori H. 2002. Silymarin,
a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced
colon carcinogenesis in male F344 rats. Int J Cancer 101(5):461-468.
146. Leslie EM, Mao Q, Oleschuk CJ, Deeley RG, Cole SP. 2001. Modulation of multidrug
resistance protein 1 (MRP1/ABCC1) transport and ATPase activities by interaction with
dietary flavonoids. Mol Pharmacol 59(5):1171-1180.
147. Critchfield JW, Welsh CJ, Phang JM, Yeh GC. 1994. Modulation of adriamycin accumu-
lation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a
putative mechanism. Biochem Pharmacol 48(7):1437-1445.
148. Scambia G, Ranelletti FO, Panici PB, De Vincenzo R, Bonanno G, Ferrandina G, Piantelli
M, Bussa S, Rumi C, Cianfriglia M, et al. 1994. Quercetin potentiates the effect of
adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein
as a possible target. Cancer Chemother Pharmacol 34(6):459-464.
149. Mitsunaga Y, Takanaga H, Matsuo H, Naito M, Tsuruo T, Ohtani H, Sawada Y. 2000. Ef-
fect of bioflavonoids on vincristine transport across blood-brain barrier. Eur J Pharmacol
395(3):193-201.
150. Chieli E, Romiti N, Cervelli F, Tongiani R. 1995. Effects of flavonols on P-glycoprotein
activity in cultured rat hepatocytes. Life Sci 57(19):1741-1751.
151. Shapiro AB, Ling V. 1997. Effect of quercetin on Hoechst 33342 transport by purified
and reconstituted P-glycoprotein. Biochem Pharmacol 53(4):587-596.
152. Kitagawa S, Nabekura T, Takahashi T, Nakamura Y, Sakamoto H, Tano H, Hirai M,
Tsukahara G. 2005. Structure-activity relationships of the inhibitory effects of flavonoids
on P-glycoprotein-mediated transport in KB-C2 cells. Biol Pharm Bull 28(12):2274-
2278.
 
Search WWH ::




Custom Search